MedTrace Logo

EDX110 - Efficacy and Safety in the Management of Hard-to-heal Wounds

NCT06640985 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2025-12-23

No results posted yet for this study

Summary

Post-market study to determine the efficacy of EDX110 dressing system in hard-to-heal wounds.

Conditions

  • Wound Healing
  • Diabetic Foot
  • Foot Ulcer, Diabetic
  • Venous Ulcer

Interventions

DEVICE

EDX110 wound dressing system

EDX110 is a dressing system comprising two layers that allows the generation of nitric oxide (NO) in situ, enables adequate moisture management and facilitates debridement

Sponsors & Collaborators

  • ConvaTec Inc.

    lead INDUSTRY

Principal Investigators

  • Jeison David Peñuela, MD · Convatec Medical Care

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-04
Primary Completion
2026-02-28
Completion
2026-02-28

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06640985 on ClinicalTrials.gov